Unnamed: 0,title,date,stock,sentiment
1213248.0,85 Biggest Movers From Yesterday,2020-06-04 05:02:00-04:00,TBIO,neutral
1213249.0,70 Biggest Movers From Yesterday,2020-05-28 06:09:00-04:00,TBIO,neutral
1213250.0,58 Stocks Moving In Wednesday's Mid-Day Session,2020-05-27 12:19:00-04:00,TBIO,neutral
1213251.0,"The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test",2020-05-20 08:12:00-04:00,TBIO,neutral
1213252.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-19 10:43:00-04:00,TBIO,neutral
1213253.0,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering",2020-05-19 08:24:00-04:00,TBIO,positive
1213254.0,82 Biggest Movers From Yesterday,2020-05-19 04:44:00-04:00,TBIO,neutral
1213255.0,Stocks That Hit 52-Week Highs On Monday,2020-05-18 10:44:00-04:00,TBIO,neutral
1213256.0,"The Daily Biotech Pulse: Co-Diagnostics Earnings, NantKwest Plans Pancreatic Cancer Study, ADC Therapeutics IPO",2020-05-15 07:49:00-04:00,TBIO,negative
1213257.0,Stocks That Hit 52-Week Highs On Thursday,2020-05-14 10:35:00-04:00,TBIO,neutral
1213258.0,"The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger",2020-05-14 08:32:00-04:00,TBIO,positive
1213259.0,75 Biggest Movers From Yesterday,2020-05-14 04:26:00-04:00,TBIO,neutral
1213260.0,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",2020-05-13 07:40:00-04:00,TBIO,neutral
1213261.0,Stocks That Hit 52-Week Highs On Tuesday,2020-05-12 10:41:00-04:00,TBIO,neutral
1213262.0,Translate Bio Q1 Sales $4.654M Up From $1.474M YoY,2020-05-07 17:32:00-04:00,TBIO,neutral
1213263.0,"Benzinga Pro's Top 5 Stocks To Watch For Mon., May 4, 2020: DIS, BMY, PTON, QTNT, TBIO",2020-05-04 08:30:00-04:00,TBIO,positive
1213264.0,UPDATE: Evercore Says Translate Bio's Coronavirus Vaccine Approach 'Seeing Strong Vaccine Potency At Lower Doses With Self-Replication',2020-05-01 10:02:00-04:00,TBIO,positive
1213265.0,"Translate Bio Shares Spike To Session High On Volume, Price Over $13; Traders Circulate Raised Price Target From Evercore ISI, From $14 To $24",2020-05-01 10:01:00-04:00,TBIO,positive
1213266.0,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update",2020-04-28 07:36:00-04:00,TBIO,neutral
1213267.0,96 Biggest Movers From Yesterday,2020-04-28 04:22:00-04:00,TBIO,neutral
1213268.0,"Shares of several healthcare companies are trading higher as equities gain strength on news that some U.S. states will reopen their economies in phases, increasing economic activity and optimism around the coronavirus pandemic.",2020-04-27 13:19:00-04:00,TBIO,positive
1213269.0,72 Stocks Moving In Monday's Mid-Day Session,2020-04-27 12:34:00-04:00,TBIO,neutral
1213270.0,Stocks That Hit 52-Week Highs On Monday,2020-04-27 10:21:00-04:00,TBIO,neutral
1213271.0,81 Biggest Movers From Friday,2020-04-27 05:33:00-04:00,TBIO,neutral
1213272.0,"The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance",2020-03-27 08:02:00-04:00,TBIO,positive
1213273.0,Sanofi and Translate Bio Collaborate to Develop Novel mRNA Vaccine Candidate Against COVID-19,2020-03-27 05:22:00-04:00,TBIO,positive
1213274.0,Translate Bio Says FDA Grants Rare Pediatric Disease Designation For MRT5050 For Treatment Of Cystic Fibrosis,2020-03-26 16:30:00-04:00,TBIO,positive
1213275.0,"Translate Bio Q4 Sales $3.89M Up From $1.182M YoY, Net Loss $31.036M",2020-03-12 16:48:00-04:00,TBIO,negative
1213276.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,TBIO,negative
1213277.0,Translate Bio Receives FDA Fast Track Designation For MRT5005 For Treatment Of Cystic Fibrosis,2020-02-26 07:41:00-05:00,TBIO,neutral
1213278.0,Translate Bio Names Paul Burgess COO,2019-12-12 16:26:00-05:00,TBIO,neutral
1213279.0,80 Biggest Movers From Yesterday,2019-12-10 05:27:00-05:00,TBIO,neutral
1213280.0,50 Biggest Movers From Friday,2019-11-25 06:30:00-05:00,TBIO,neutral
1213281.0,77 Biggest Movers From Yesterday,2019-11-20 04:57:00-05:00,TBIO,neutral
1213282.0,"Translate Bio Q3 Net Loss $21.227M vs $42.646M In Same Qtr. Last Year, Sales $1.266M Up From $238K YoY",2019-11-06 17:09:00-05:00,TBIO,negative
1213283.0,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",2019-10-27 12:56:00-04:00,TBIO,neutral
1213284.0,58 Biggest Movers From Friday,2019-10-14 03:51:00-04:00,TBIO,neutral
1213285.0,52 Biggest Movers From Yesterday,2019-09-19 05:18:00-04:00,TBIO,neutral
1213286.0,36 Stocks Moving In Wednesday's Mid-Day Session,2019-09-18 13:19:00-04:00,TBIO,neutral
1213287.0,Translate Bio shares are trading lower after the company priced a 9 million share offering of its common stock at $10 per share.,2019-09-18 08:28:00-04:00,TBIO,positive
1213288.0,10 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-09-18 08:13:00-04:00,TBIO,neutral
1213289.0,30 Stocks Moving in Wednesday's Pre-Market Session,2019-09-18 07:52:00-04:00,TBIO,neutral
1213290.0,"The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts",2019-09-18 07:39:00-04:00,TBIO,neutral
1213291.0,A Peek Into The Markets: US Stock Futures Edge Lower; All Eyes On Fed Decision,2019-09-18 07:01:00-04:00,TBIO,negative
1213292.0,Translate Bio Prices 9M Share Offering of Public Offering of Common Stock @$10/Share,2019-09-18 04:26:00-04:00,TBIO,positive
1213293.0,7 Stocks Moving In Tuesday's After-Hours Session,2019-09-17 16:35:00-04:00,TBIO,neutral
1213294.0,Translate Bio shares are trading lower after the company reported a $90 million common stock offering.,2019-09-17 16:14:00-04:00,TBIO,neutral
1213295.0,Translate Bio Reports $90M Common Stock Offering,2019-09-17 16:13:00-04:00,TBIO,neutral
1213296.0,Translate Bio Announces Strategic Manufacturing Agreement With AMRI In Support Of Messenger RNA Manufacturing,2019-09-12 16:08:00-04:00,TBIO,positive
1213297.0,50 Stocks Moving In Tuesday's Mid-Day Session,2019-09-10 12:19:00-04:00,TBIO,neutral
1213298.0,28 Stocks Moving in Tuesday's Pre-Market Session,2019-09-10 07:51:00-04:00,TBIO,neutral
1213299.0,"The Daily Biotech Pulse: Translate Bio Halts mRNA Therapy Trial, Roche Multiple Sclerosis Biomarker Data, D-Day For Xeris",2019-09-10 07:36:00-04:00,TBIO,neutral
1213300.0,A Peek Into The Markets: US Stock Futures Down Ahead Of JOLTS Report,2019-09-10 06:31:00-04:00,TBIO,neutral
1213301.0,"7 Stocks To Watch For September 10, 2019",2019-09-10 04:39:00-04:00,TBIO,neutral
1213302.0,4 Stocks Moving In Monday's After-Hours Session,2019-09-09 17:06:00-04:00,TBIO,neutral
1213303.0,Translate Bio shares are trading lower after the company announced it would discontinue the development of its MRT5201.,2019-09-09 16:10:00-04:00,TBIO,neutral
1213304.0,"Translate Bio Discontinuing Development Of MRT5201, A Liver-targeted Treatment For Ornithine Transcarbamylase Deficiency",2019-09-09 16:07:00-04:00,TBIO,neutral
1213305.0,88 Biggest Movers From Yesterday,2019-08-01 05:41:00-04:00,TBIO,neutral
1213306.0,"Translate Bio Q2 Net Loss $27.832M vs $27.503M In Same Qtr. Last Year, Sales $1.174M",2019-07-31 08:11:00-04:00,TBIO,negative
1213307.0,Translate Bio Announces Interim Results From Phase 1/2 Clinical Trial Of MRT5005 In Patients With Cystic Fibrosis; Drug Well Tolerated At Low Mid Mid-Dose Levels,2019-07-31 06:54:00-04:00,TBIO,neutral
1213308.0,"Jefferies Initiates Coverage On Translate Bio with Buy Rating, Announces $20 Price Target",2019-07-22 08:49:00-04:00,TBIO,neutral
1213309.0,Translate Bio Inc Files For Resale Of Up To 5.6M Shares Of Common Stock By Selling Stockholders,2019-07-10 16:23:00-04:00,TBIO,positive
1213310.0,Translate Bio shares are trading higher after the company received FDA clearance to proceed with a single-ascending dose phase 1/2 clinical trial for Ornithine Transcarbamylase Deficiency.,2019-06-26 14:23:00-04:00,TBIO,positive
1213311.0,FDA Lifts Clinical Hold On Translate Bio's Liver Disorder Trial,2019-06-26 11:21:00-04:00,TBIO,negative
1213312.0,Translate Bio Announces FDA Clearance To Proceed With A Single-ascending Dose (SAD) Phase 1/2 Clinical Trial For Ornithine Transcarbamylase (OTC) Deficiency,2019-06-26 07:03:00-04:00,TBIO,neutral
1213313.0,54 Biggest Movers From Yesterday,2019-06-21 04:56:00-04:00,TBIO,neutral
1213314.0,"Benzinga's Top Upgrades, Downgrades For June 18, 2019",2019-06-18 09:11:00-04:00,TBIO,positive
1213315.0,"Roth Capital Initiates Coverage On Translate Bio with Buy Rating, Announces $25 Price Target",2019-06-18 07:46:00-04:00,TBIO,neutral
1213316.0,Shares of many healthcare companies are trading lower following a tweet from President Trump late Thursday stating the US will impose a 5 percent tariff on goods from Mexico.,2019-05-31 10:25:00-04:00,TBIO,negative
1213317.0,52 Biggest Movers From Yesterday,2019-05-21 05:05:00-04:00,TBIO,neutral
1213318.0,36 Stocks Moving In Monday's Mid-Day Session,2019-05-20 12:32:00-04:00,TBIO,neutral
1213319.0,58 Biggest Movers From Yesterday,2019-05-15 05:09:00-04:00,TBIO,neutral
1213320.0,Translate Bio Reports Q1 Revenues Of $1.4M Reports Q1 Net Loss Of $33.2M Vs. A Net Loss Of $21.2M In The Prior Year; Completed Dosing In Single-Ascending Dose Portion Of Phase 1/2 Clinical Trial In Cystic Fibrosis; Data Expected 3Q19,2019-05-09 17:43:00-04:00,TBIO,negative
1213321.0,Translate Bio Announces $47.5M Private Placement,2019-05-01 07:41:00-04:00,TBIO,neutral
1213322.0,Translate Bio Highlights Oral Presentation Of mRNA Therapeutics In Models Of Metabolic Disorders At ASGCT Meeting,2019-04-29 08:47:00-04:00,TBIO,neutral
1213323.0,21 Stocks Moving In Tuesday's Pre-Market Session,2019-04-16 08:06:00-04:00,TBIO,neutral
1213324.0,Translate Bio Presents Preclinical Data Supporting MRT5201 For The Treatment Of Ornithine Transcarbamylase (OTC) Deficiency At The Society For Inherited Metabolic Disorders (SIMD) Annual Meeting,2019-04-08 16:07:00-04:00,TBIO,positive
1213325.0,58 Biggest Movers From Yesterday,2019-04-02 05:45:00-04:00,TBIO,neutral
1213326.0,46 Stocks Moving In Monday's Mid-Day Session,2019-04-01 13:06:00-04:00,TBIO,neutral
1213327.0,Translate Bio Reports Granted US Patent For mRNA Delivery,2019-03-26 07:35:00-04:00,TBIO,positive
1213328.0,"Translate Bio Q4 Collaboration Revenue $1.18M, Net Income $(1.04M) vs $(16.09M) YoY",2019-03-21 16:30:00-04:00,TBIO,neutral
1213329.0,60 Biggest Movers From Yesterday,2019-03-19 05:24:00-04:00,TBIO,neutral
1213330.0,Translate Bio Highlights Publication Of Preclinical Data Demonstrating Efficacy Of Systemic mRNA Delivery In Fabry Disease Model In The Journal Molecular Therapy,2019-03-18 07:35:00-04:00,TBIO,neutral
1213331.0,70 Biggest Movers From Friday,2019-03-11 05:26:00-04:00,TBIO,neutral
1213332.0,50 Stocks Moving In Friday's Mid-Day Session,2019-03-08 12:31:00-05:00,TBIO,neutral
1213333.0,62 Biggest Movers From Yesterday,2019-03-05 05:19:00-05:00,TBIO,neutral
1213334.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,TBIO,positive
1213335.0,Translate Bio Provides Updates On Cystic Fibrosis (CF) And Ornithine Transcarbamylase (OTC) Deficiency Programs,2019-02-27 17:27:00-05:00,TBIO,neutral
1213336.0,71 Biggest Movers From Yesterday,2019-02-20 04:49:00-05:00,TBIO,neutral
1213337.0,54 Stocks Moving In Tuesday's Mid-Day Session,2019-02-19 13:01:00-05:00,TBIO,neutral
1213338.0,61 Biggest Movers From Friday,2019-02-19 05:14:00-05:00,TBIO,neutral
1213339.0,55 Biggest Movers From Yesterday,2019-01-23 05:19:00-05:00,TBIO,neutral
1213340.0,Translate Bio Announces FDA Clinical Hold On Investigational New Drug Application For MRT5201 For Treatment Of Ornithine Transcarbamylase Deficiency Until FDA Questions Are Resolved,2019-01-22 07:33:00-05:00,TBIO,positive
1213341.0,55 Biggest Movers From Yesterday,2019-01-11 05:45:00-05:00,TBIO,neutral
1213342.0,65 Biggest Movers From Yesterday,2019-01-08 05:16:00-05:00,TBIO,neutral
1213343.0,58 Biggest Movers From Friday,2019-01-07 04:17:00-05:00,TBIO,neutral
1213344.0,"Translate Bio Reports Advancement Of Cystic Fibrosis, Ornithine Transcarbamylase Deficiency",2019-01-03 07:40:00-05:00,TBIO,neutral
1213345.0,"Benzinga's Top Upgrades, Downgrades For December 24, 2018",2018-12-24 08:57:00-05:00,TBIO,positive
1213346.0,"H.C. Wainwright Initiates Coverage On Translate Bio with Buy Rating, Announces $21 Price Target",2018-12-24 07:12:00-05:00,TBIO,neutral
1213347.0,60 Biggest Movers From Friday,2018-12-24 04:35:00-05:00,TBIO,neutral
1213348.0,40 Stocks Moving In Friday's Mid-Day Session,2018-12-21 12:40:00-05:00,TBIO,neutral
1213349.0,Translate Bio Reports U.S. Patent Relating To Its Messenger RNA Therapeutics Platform,2018-12-04 09:17:00-05:00,TBIO,neutral
1213350.0,64 Biggest Movers From Yesterday,2018-11-16 04:58:00-05:00,TBIO,neutral
1213351.0,"The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering",2018-10-24 07:48:00-04:00,TBIO,positive
1213352.0,"The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs",2018-10-18 07:56:00-04:00,TBIO,positive
1213353.0,Mid-Morning Market Update: Markets Open Higher; Goldman Sachs Profit Tops Expectations,2018-10-16 10:25:00-04:00,TBIO,positive
1213354.0,"The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist",2018-10-16 08:52:00-04:00,TBIO,positive
1213355.0,"The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",2018-10-12 07:34:00-04:00,TBIO,negative
1213356.0,"The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares",2018-10-11 07:39:00-04:00,TBIO,positive
1213357.0,"Stocks Which Set New 52-Week Low Friday, October 5th",2018-10-08 09:27:00-04:00,TBIO,negative
1213358.0,"The Daily Biotech Pulse: MediciNova Gets Orphan-Drug Status, KemPharm To Offer Shares, Emergent Buys Vaccine Maker",2018-10-05 08:35:00-04:00,TBIO,positive
1213359.0,45 Biggest Movers From Yesterday,2018-08-17 05:37:00-04:00,TBIO,neutral
1213360.0,Translate Bio Q2 EPS $(0.61) Beats $(0.62) Est.,2018-08-09 16:22:00-04:00,TBIO,neutral
1213361.0,"Stocks Which Set New 52-Week Low Yesterday, August 6th",2018-08-07 11:28:00-04:00,TBIO,negative
1213362.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,TBIO,negative
1213363.0,"IPO Lockup Expirations Today For: BJ's Wholesale, Brightview, Entera Bio, EverQuote, Forty Seven, HL Acquisitions Corp, Translate Bio, Tricida, and Neuronetics",2018-08-07 06:45:00-04:00,TBIO,neutral
1213364.0,52 Biggest Movers From Yesterday,2018-08-07 05:19:00-04:00,TBIO,neutral
1213365.0,"The Week Ahead: Earnings From Disney, Roku And Snap, Rite Aid Votes On Albertsons Deal",2018-08-06 15:30:00-04:00,TBIO,neutral
1213366.0,Translate Bio shares trading down 10.9%; Not seeing any news or clear catalyst to justify price action.,2018-08-06 14:30:00-04:00,TBIO,positive
1213367.0,"Stocks Which Set New 52-Week Low Yesterday, July 31",2018-08-01 12:16:00-04:00,TBIO,negative
1213368.0,"Benzinga's Biotech Pulse: Pfizer's Xeljanz Gets EU Nod, NewLink Losses Narrow, Neuralstem Commences Stroke Drug Trial",2018-08-01 09:01:00-04:00,TBIO,negative
1213369.0,65 Biggest Movers From Yesterday,2018-08-01 04:36:00-04:00,TBIO,neutral
1213370.0,52 Stocks Moving In Tuesday's Mid-Day Session,2018-07-31 12:38:00-04:00,TBIO,neutral
1213371.0,50 Biggest Movers From Yesterday,2018-07-31 04:23:00-04:00,TBIO,neutral
1213372.0,Leerink: Translate Bio's Cystic Fibrosis Candidate Could Generate $1.8B,2018-07-23 16:48:00-04:00,TBIO,neutral
1213373.0,"The Week Ahead: FANG Earnings Continue, Fox Vote On Disney Deal, More IPOs",2018-07-23 12:41:00-04:00,TBIO,neutral
1213374.0,Stocks Which Set New 52-Week Highs Friday,2018-07-23 11:08:00-04:00,TBIO,neutral
1213375.0,"Translate Bio's Novel mRNA Therapy Candidate Addresses A Key Investor Concern, Citi Says",2018-07-23 11:00:00-04:00,TBIO,positive
1213376.0,"Leerink Swann Initiates Coverage On Translate Bio with Outperform Rating, Announces $24 Price Target",2018-07-23 08:38:00-04:00,TBIO,neutral
1213377.0,"Citigroup Initiates Coverage On Translate Bio with Buy Rating, Announces $20 Price Target",2018-07-23 07:48:00-04:00,TBIO,neutral
1213378.0,"Analyst Quiet Period Expirations Today For: BJ's Wholesale, The Lovesac, Tricida, Brightview, Neon Therapeutics, Neuronetics, Everquote, HyreCar, Forty Seven, Translate Bio, and Uxin",2018-07-23 07:39:00-04:00,TBIO,neutral
1213379.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-07-22 17:03:00-04:00,TBIO,neutral
1213380.0,"Benzinga's Daily Biotech Pulse: Novartis Licenses Skin Drug, 2 Stocks To Debut",2018-07-19 09:14:00-04:00,TBIO,neutral
1213381.0,13G Filing Shows Baupost Group Reporting New 14.5% Stake In Translate Bio,2018-07-09 16:07:00-04:00,TBIO,neutral
1213382.0,"UPDATE: GlaxoSmithKline Says Co.'s Wholly-Owned Indrect Subsidiary SR One Bought ~269K Shares Of Translate Bio At $13/Share On Jul. 2, 2018",2018-07-05 16:48:00-04:00,TBIO,positive
1213383.0,"Benzinga's Daily Biotech Pulse: Titan's Parkinson's Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% Premium",2018-07-03 07:51:00-04:00,TBIO,neutral
1213384.0,48 Biggest Movers From Yesterday,2018-06-29 04:06:00-04:00,TBIO,neutral
1213385.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-06-28 13:03:00-04:00,TBIO,neutral
1213386.0,"Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut",2018-06-28 08:26:00-04:00,TBIO,positive
1213387.0,Translate Bio Prices 9.35M Share IPO @$13/Share,2018-06-28 04:31:00-04:00,TBIO,positive
1213388.0,"The IPO Outlook For The Week: Shipping, Medtech, Mobility And Retail",2018-06-24 11:02:00-04:00,TBIO,neutral
1213389.0,12 Biggest Mid-Day Gainers For Friday,2017-01-13 12:16:00-05:00,TBIO,neutral
1213390.0,Transgemonic Up Another 33% Following Yesterday's 295% Run,2017-01-13 08:38:00-05:00,TBIO,neutral
1213391.0,Mid-Afternoon Market Update: Crude Oil Up 1.5%; Applied Optoelectronics Shares Soar On Raised Guidance,2017-01-12 14:34:00-05:00,TBIO,negative
1213392.0,12 Biggest Mid-Day Gainers For Thursday,2017-01-12 12:30:00-05:00,TBIO,neutral
1213393.0,Mid-Day Market Update: Dow Falls 170 Points; Straight Path Shares Surge On FCC Settlement,2017-01-12 12:13:00-05:00,TBIO,positive
1213394.0,Mid-Morning Market Update: Markets Open Lower; Delta Air Posts In-Line Profit,2017-01-12 10:36:00-05:00,TBIO,positive
1213395.0,Transgenomic +170% Premarket @ $0.78 After Announcing Licensing Agreement with LifeLabs,2017-01-12 08:58:00-05:00,TBIO,positive
1213396.0,20 Stocks Moving In Thursday's Pre-Market Session,2017-01-12 08:28:00-05:00,TBIO,neutral
1213397.0,"Transgenomic Announces Licensing Agreement with LifeLabs, Terms Not Disclosed",2017-01-12 07:33:00-05:00,TBIO,positive
1213398.0,"Transgenomic, Precipio Diagnostics to Merge; Precipio Shareholders to Receive 62%-80% of Outstanding Shares of Combined Precipio Company",2016-10-13 03:32:00-04:00,TBIO,positive
1213399.0,Transgenomic Says Specialists in China and India Have Signed to Distribute ICE COLD PCR Kits,2016-09-29 07:05:00-04:00,TBIO,neutral
1213400.0,"Transgenomic, Ventana Medical Systems Complete Data Sharing Agreement",2016-09-22 07:30:00-04:00,TBIO,positive
1213401.0,4 Stocks Moving In Friday's After-Hours Session,2016-08-12 17:19:00-04:00,TBIO,neutral
1213402.0,Transgenomic Reports Q2 EPS $(0.10) vs. Prior Year Quarter $(0.26),2016-08-12 16:06:00-04:00,TBIO,neutral
1213403.0,"Earnings Scheduled For August 12, 2016",2016-08-12 05:04:00-04:00,TBIO,neutral
1213404.0,Stocks Hitting 52-Week Lows,2016-07-21 10:57:00-04:00,TBIO,negative
1213405.0,Transgenomic Licenses Commercial Rights to Its Long QT Syndrome DNA Testing Portfolio to LabCorp,2016-07-20 07:32:00-04:00,TBIO,positive
1213406.0,"Nasdaq Granted Transgenomic Maximum Allowable 180-day Extension to October 17, 2016 to Evidence Compliance with Minimum Stockholders' Equity Requirement -8K",2016-07-06 06:09:00-04:00,TBIO,positive
1213407.0,Transgenomic Reports Acceleration of Commercialization of ICP Amid Plans to Expand Cancer Product Line Ten-Fold,2016-06-14 07:15:00-04:00,TBIO,negative
1213408.0,"Transgenomic Reports Release of New Data at ASCO Confirming Concordance of ICP Liquid, Tissue Biopsies",2016-06-07 07:15:00-04:00,TBIO,neutral
1213409.0,"Transgenomic Reports Q1 EPS from Continuing Operations $(0.10) vs $(0.28) in Same Qtr. Last Year, Sales $236K",2016-05-24 07:06:00-04:00,TBIO,neutral
1213410.0,"Transgenomic Study Data Shows 100% Concordance between ICE COLD-PCR Liquid Biopsies and Conventional Tissue Biopsy Results, Also Shows More Tumor Mutations Than Current Standard Methods",2016-05-16 07:30:00-04:00,TBIO,negative
1213411.0,Nasdaq Says Transgenomic Not in Compliance With $2.5M Minimum Stockholders' Equity Requirement,2016-04-26 06:17:00-04:00,TBIO,neutral
1213412.0,Transgenomic Announces First Rapid Turnaround Liquid Biopsy Metastatic Breast Cancer Panel at AACR Meeting,2016-04-19 07:33:00-04:00,TBIO,negative
1213413.0,"Transgenomic Reports FY15 EPS from Continuing Operations $(0.93) vs $(1.59) in FY14, Sales $1.65M vs $1.24M YoY",2016-04-14 16:11:00-04:00,TBIO,neutral
1213414.0,Transgenomic Launches First Commercially Available Assay for Ultra Low Level Detection of EGFR C797S Mutations That Predict Resistance to Third Generation Kinase Therapies for Lung Cancer,2016-03-18 07:33:00-04:00,TBIO,negative
1213415.0,Transgenomic Announces New MX-ICP Liquid Biopsy Tests to Detect Colorectal and Melanoma Tumor Mutations,2016-03-10 07:34:00-05:00,TBIO,negative
1213416.0,S-3 from Transgenomic Shows Registration for ~7.12M Common Shares via Selling Holders,2016-01-25 16:58:00-05:00,TBIO,positive
1213417.0,Transgenomic Reports Winning of NIH Grant to Augment Multiplexing Capabilities of ICE COLD-PCR Technology in Collab with Dana-Farber Cancer Institute,2015-12-23 07:30:00-05:00,TBIO,positive
1213418.0,"Transgenomic Reports Q3 EPS $(0.55) Vs Est $(0.22), Sales $3.96M Vs Est $6.65M",2015-11-12 16:43:00-05:00,TBIO,neutral
1213419.0,Transgenomic Signs Binding Term Sheet to Divest Genetic Assays & Platforms Business Unit,2015-09-30 09:15:00-04:00,TBIO,neutral
1213420.0,"StoneCalibre Acquires Ion Chromatography Business From Transgenomic, Inc.",2015-09-10 09:00:00-04:00,TBIO,neutral
1213421.0,"Transgenomic Announces Sale of Ion Chromatography Product Line, Assets to Edge Biosystems; No Terms Disclosed",2015-09-09 07:32:00-04:00,TBIO,negative
1213422.0,Transgenomic Reports Q2 Loss $0.30 Vs Est Loss $0.41,2015-08-13 16:05:00-04:00,TBIO,negative
1213423.0,"Tuesday's Mid-Day Movers: Iran's Nuclear Deal Reached; Micron Technology Bid, Box Inc And More",2015-07-14 12:31:00-04:00,TBIO,positive
1213424.0,Morning Market Gainers,2015-07-14 09:38:00-04:00,TBIO,neutral
1213425.0,Benzinga's Top #PreMarket Gainers,2015-07-14 08:13:00-04:00,TBIO,positive
1213426.0,Transgenomic Shares Rise 12% Premarket Following Announcement of Launch of Genetic Test for Diagnosis of Leukodystrophy,2015-07-14 08:06:00-04:00,TBIO,positive
1213427.0,Morning Market Gainers,2015-07-01 09:41:00-04:00,TBIO,neutral
1213428.0,Transgenomic Reports Private Placement of $3M in Gross Proceeds,2015-07-01 07:30:00-04:00,TBIO,negative
1213429.0,Morning Market Gainers,2015-06-22 09:43:00-04:00,TBIO,neutral
1213430.0,Transgenomic To Launch Liquid Biopsy Cancer Test Pipeline During 2015,2015-06-22 07:03:00-04:00,TBIO,negative
1213431.0,Note Being Circulated Says TBIO News Was Out on May 14,2015-05-29 09:54:00-04:00,TBIO,neutral
1213432.0,Morning Market Gainers,2015-05-29 09:46:00-04:00,TBIO,neutral
1213433.0,Transgenomic Launches EGFR CLIA Test That Accurately Detects Key Mutations in Solid and Liquid Patient Samples Using Multiplexed ICE COLD-PCR,2015-05-29 07:16:00-04:00,TBIO,positive
1213434.0,"Transgenomic Reports Q1 Loss $0.36 Vs Est Los $0.52, Sales $6.51M Vs Est $6.80M",2015-05-14 16:16:00-04:00,TBIO,negative
1213435.0,"Transgenomic, Horizon Discovery Announces OEM Agreement",2015-04-23 04:30:00-04:00,TBIO,positive
1213436.0,Transgenomic Strengthens License Agreement With Exiqon For ICE COLD-PCR Global Commercialization,2015-03-11 07:16:00-04:00,TBIO,positive
1213437.0,Transgenomic Prices ~3.573M Share Offering Plus Warrants to Purchase ~715K Shares for Net Proceeds of ~$6.2M,2015-02-27 06:42:00-05:00,TBIO,positive
1213438.0,Transgenomic Commences Common Stock Offering,2015-02-26 17:03:00-05:00,TBIO,neutral
1213439.0,Parsley Energy Announces Private Placement of Common Stock To Sell 14.8M Class A Shares,2015-02-06 09:27:00-05:00,TBIO,positive
1213440.0,S-3: Transgenomic Files $50M Shelf Offering,2015-02-06 09:14:00-05:00,TBIO,neutral
1213441.0,Transgenomic Reports Q1 Launch of Multiplexed Ice Cold-PCRTM Technology,2015-01-14 08:08:00-05:00,TBIO,neutral
1213442.0,Transgenomic Collaborates With Researchers To Advance Understanding Of Genetic Disease Tuberous Sclerosis,2014-11-19 07:30:00-05:00,TBIO,neutral
1213443.0,Transgenomic Announces CFO Mark Colonnese Has Resigned; Paul Kinnon To Interim CFO,2014-11-05 08:35:00-05:00,TBIO,negative
1213444.0,Transgenomic Announces $2.375M Private Placement Financing ,2014-10-22 16:20:00-04:00,TBIO,neutral
1213445.0,"Transgenomic Announces Right Sale For Surveyor to Integrated DNA Technologies For $4.25M, Minimum",2014-07-02 07:02:00-04:00,TBIO,neutral
1213446.0,Transgenomic Licenses Exclusive Rights to Multiplexed ICE COLD-PCRTM Technology ,2014-05-28 07:06:00-04:00,TBIO,positive
1213447.0,Transgenomic in Collaboration Agreement with Amgen,2013-05-06 07:07:00-04:00,TBIO,positive
1213448.0,Transgenomic Secures $8M Credit Line,2013-03-13 16:13:00-04:00,TBIO,positive
1213449.0,Transgenomic Announces $3 Million Convertible Note Financing   ,2012-01-06 10:14:00-05:00,TBIO,neutral
